-
Arena Pharmaceuticals to Host Key Opinion Leader Event on S1P Modulation and Etrasimod in Autoimmune Diseases on January 29 in New York City
22 Jan 2018 22:25 GMT
… the event.
Additionally, Arena Pharmaceuticals' management team … other diseases including hydrocephalus, schizophrenia, neuropathic pain and fibrosis … ulcerative colitis.
About Arena Pharmaceuticals
Arena Pharmaceuticals is a biopharmaceutical company …
-
Regulatory tracker: Sobi, Apellis' Empaveli scores EU approval for first-line PNH treatment
03 Jan 2024 17:45 GMT
… approval for its long-acting schizophrenia treatment Risvan.
Risvan is a … is approved for use in schizophrenia patients as an every-other … through its $6.7 billion Arena Pharmaceuticals acquisition. The drug rivals Bristol …
-
3 Insanely Expensive Stocks To Avoid
21 Feb 2023 21:34 GMT
… a drug (KarXT) to combat schizophrenia and psychosis associated with Alzheimer … Therapeutics
NTLA
is down 53%. Arena Pharmaceuticals
ARNA
is up 7%.
Disclosure …
-
Global Cannabinoid Derived Pharmaceutical Market Assessment worth US$ 11.2 Billion by 2030-Report by InsightAce Analytic
19 Aug 2022 11:52 GMT
… , Migraine, Multiple Sclerosis, Schizophrenia, and Others), Trends, … ., Cannabics Pharmaceuticals Inc., Arena Pharmaceuticals, One World Cannabis, Echo … • Migraine
• Multiple Sclerosis
• Schizophrenia
• Others
Global Cannabinoid Derived Pharmaceutical …
-
AbbVie: Superb 2021 Paves Way For Further Outperformance In 2022
09 Feb 2022 17:41 GMT
… for both Bipolar disorder and Schizophrenia, earned $489m last year for … are also S1P modulators like Arena Pharmaceuticals' (ARNA) Etrasimod or Bristol …
-
Global Psychiatry Deals Report 2014-2021: Access to Headline, Upfront, Milestone and Royalty Data - ResearchAndMarkets.com
08 Dec 2021 13:03 GMT
… , Obsessive compulsive disorder, Personality disorder, Schizophrenia, Sleep disorders, Insomnia, Narcolepsy, Sleep … Biotech
ARCH Personalized Medicine Initiative
Arena Pharmaceuticals
Arizona State University
Armor
Artelo …
-
The Daily Biotech Pulse: FDA Panel Review For Alkermes, Axovant Gets Rare Pediatric Disease Designation, 2 IPOs
09 Oct 2020 11:26 GMT
… )
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN)
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA)
argenx SE … for the proposed indications of schizophrenia and bipolar I disorder.
The …
-
The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering
07 Jan 2020 13:42 GMT
… received FDA approval for its schizophrenia drug lumateperone, said it has … Growth With Expanded Pipeline, Collaboration
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) said its …
-
10 Pharma Stocks To Watch This Month
02 Sep 2018 15:17 GMT
… stick to their timeline).
1. Arena Pharmaceuticals Inc. (ARNA)
Arena is a … for Huntington's and Schizophrenia, OMS405 for Opioid and Nicotine …
-
Denovo Biopharma Opens New R&D Center, Names Chief Medical Officer and Chief Financial Officer
03 Jan 2018 11:37 GMT
… at Pfizer, Bristol-Myers Squibb, Arena Pharmaceuticals and Exelixis. Dr. Shazer received … : DB102 for oncology, DB103 for schizophrenia, and DB104 for depression. For …